Spontaneous adverse-event systems can reveal recurring reports across countries. The count of those reports has no corresponding count of every exposed patient, so it cannot directly supply a rate of delirium among people who took zolpidem.
How the cross-national comparison worked
Researchers used prespecified delirium-related terms and compared reports in the United States, Japan and Canada. The analysis included more than 263,000 reports meeting the study’s case definition across the three systems. Zolpidem was among the drugs with consistent disproportionality signals. Such a signal compares the relative prominence of a drug-event pair in a reporting database.
Applying the finding to an individual timeline
Reporting can vary with clinical attention, access, concurrent medications and recognition of symptoms. When assessing a single event, the administration and symptom times, underlying illness, other exposures and contemporaneous observations help evaluate the causal explanation. The three-database result makes the association worth investigating without giving an individual probability.
Leave a Reply